Showing results (701-710 of 737) with videos related to
Sort By:
Pageof 74
Human Molecular Genetics|April 20, 2010
Genome-wide association of anthropometric traits in African- and African-derived populationsSun J Kang, Charleston W K Chiang, Cameron D Palmer, et al.Plos Genetics|March 12, 2010
Rapid assessment of genetic ancestry in populations of unknown origin by genome-wide genotyping of pooled samplesCharleston W K Chiang, Zofia K Z Gajdos, Joshua M Korn, et al.Journal of the National Cancer Institute|December 22, 2017
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer ImmunotherapyJodi A McKenzie, Rina M Mbofung, Shruti Malu, et al.Vaccine|July 28, 2026
The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adultsMcLeod C, M Dymock, K L Flanagan, et al.Medicine|October 6, 2023
Sodium and potassium consumption in Jamaica: National estimates and associated factors from the Jamaica Health and Lifestyle Survey 2016-2017Trevor S Ferguson, Novie O M Younger-Coleman, Karen Webster-Kerr, et al.BMJ Open|December 10, 2023
Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UKTimothy Simon Walsh, Leanne M Aitken, Cathrine A McKenzie, et al.Nature Communications|September 8, 2017
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genesRina M Mbofung, Jodi A McKenzie, Shruti Malu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2018
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A ExpressionLu Huang, Shruti Malu, Jodi A McKenzie, et al.Health Technology Assessment (Winchester, England)|July 1, 2026
Alpha2 agonists for sedation to produce better outcomes for adults with critical illness: a synopsis of the A2B RCT with cost-effectiveness and process evaluationTimothy S Walsh, Richard A Parker, Leanne M Aitken, et al.Cancer Immunology, Immunotherapy : CII|October 30, 2020
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicitySimone Punt, Shruti Malu, Jodi A McKenzie, et al.Pageof 74